RBN-3143

• CAT Number: I042293
• CAS Number: 2360853-16-1
• Molecular Formula: C22H28FN3O4S
• Molecular Weight: 449.54
• Purity: ≥95%
• Synonyms: 7-[(1-acetylpiperidin-4-yl)methoxy]-5-fluoro-2-(oxan-4-ylsulfanylmethyl)-3H-quinazolin-4-one
• InChI: InChI=1S/C22H28FN3O4S/c1-14(27)26-6-2-15(3-7-26)12-30-16-10-18(23)21-19(11-16)24-20(25-22(21)28)13-31-17-4-8-29-9-5-17/h10-11,15,17H,2-9,12-13H2,1H3,(H,24,25,28)
• InChIKey: LLXIEISWIFSUBQ-UHFFFAOYSA-N
• SMILES: CC(=O)N1CCC(CC1)COC2=CC3=C(C(=C2)F)C(=O)NC(=N3)CSC4CCOCC4

RBN-3143（Cat No.:I042293）is an experimental small molecule developed as a potential therapeutic agent for cancer treatment. It works by targeting specific molecular pathways involved in tumor growth and survival, particularly in cancers that are resistant to traditional therapies. Preclinical studies suggest that RBN-3143 may inhibit key proteins responsible for cancer cell proliferation and survival, leading to tumor regression. It holds promise in treating solid tumors, including those with mutations that affect cellular signaling pathways. Ongoing research and clinical trials are evaluating its safety, efficacy, and potential as part of personalized cancer treatment strategies.